Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HgCapital invests £11.5m in Iberian B2B software firms

(Sharecast News) - HgCapital Trust announced an investment in CTAIMA and E-coordina, two Iberian companies specialising in contractor management, risk, and compliance software, on Friday.

The London-listed firm said the financial terms of the transaction were not being disclosed, but said it would invest around £11.5m, with other institutional clients of Hg also participating through the Hg Mercury 4 Fund.

It said the investment was Hg's first platform investment in Iberia, continuing its focus on mission-critical B2B compliance software.

The merger of CTAIMA and E-coordina was designed to create a leading contractor compliance platform in the Iberian market, with co-CEOs Lorenzo Zavala and Luis de los Santos at the helm to drive growth and innovation.

The new entity was expected to enhance its product offering and expand its reach across Europe and Latin America, building on significant growth already achieved by both companies.

CTAIMA, based in Tarragona, Spain, had evolved from a consulting firm into an international software-as-a-service platform, connecting over 100,000 contractors and subcontractors with more than 1,000 clients across 17 countries.

Following the transaction, HgCapital Trust's liquid resources available for future investments were estimated to be £496m, representing 21% of its estimated net asset value as of 30 June.

The investment reduced its outstanding commitments to invest in Hg transactions to about £713m, or 30% of the estimated net asset value.

At 1041 BST, shares in HgCapital Trust were down 3.83% at 527p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

PepsiCo cuts revenue outlook again
(Sharecast News) - PepsiCo cut its annual organic revenue guidance again on Tuesday as it highlighted a "subdued" performance in North America in the third quarter.
Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.